<img src="https://trc.taboola.com/1321591/log/3/unip?en=page_view" width="0" height="0" style="display:none">
Fact Check Library

Fact Check with Logically.

Download the Free App Today

true
true

CLAIM ID

1aae8263

At least 400 cases of the U.K, South African, and Brazilian variants of COVID-19 cases have been confirmed in India.

India has recorded nearly 400 cases of COVID-19 infections from the UK, South African, and Brazilian variants in March 2021.

India has recorded nearly 400 cases of COVID-19 infections from the UK, South African, and Brazilian variants in March 2021.India reported the highest single-day spike of COVID-19 cases on March 17, 2021, with 35,871 cases and 172 deaths, according to the data released by the Union Health Ministry.

Amid the surge in cases, the ministry added that the number of COVID-19 infections from the UK, South African, and Brazilian mutant variants stood at 400 in total as of March 17. Out of these 400 cases, 158 were reported within the past two weeks, before which only 242 cases of these COVID-19 variants were reported across the country.

Minister of State for Health Ashwini Choubey in Rajya Sabha said that the three variants are believed to be more contagious and that they could have the ability to reinfect a recovered person. However, the minister noted that there are no cases of reinfection from the mutant variants in the country as of now.

The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.

Have a question or correction on one of our fact-checks?

If you think a claim has been misjudged or requires correction, please send us evidence to support your error claim. We will revisit our evidence and verdict and conduct additional research to verify new information.

Fact Check of the Day

misleading

397 children were diagnosed with heart inflammation after receiving Pfizer’s COVID-19 vaccine in U.S.